Skip to content

President-elect Trump affirms support for PBM reform

With the growing demand for PBM reform, Trump has stated that action must be taken.

ARLINGTON, Va. – As demands for PBM reform grow, President-elect Donald Trump said the following at a news conference yesterday at Mar-a-Lago:

“We are paying far too much, because we are paying far more than other countries. We have laws that make it impossible to reduce [drug costs] and we have a thing called a ‘middleman’ … that makes more money than the drug companies, and they don’t do anything except they’re middlemen. We are going to knock out the middleman.”

Trump’s statement yesterday follows his remarks on December 8 during an interview on Meet the Press:

We’re going to do a lot of things. Number one, we’re going to reduce prices – because the middleman makes more money than the drug companies in all fairness to the drug companies. There’s a middleman that nobody even knows who they are.”

Pharmacy organizations rally behind PBM reform legislation
Pharmacy leaders demand Congress address PBM practices.
NACDS to Capitol Hill: Stand strong on PBM reform
NACDS: “As the continuing resolution is finalized, Americans and their pharmacies are watching and waiting for real PBM reform now to lower drug costs and to protect pharmacy access”.

Comments

Latest

Ferrero reportedly will buy Kellogg for $3 billion

Ferrero reportedly will buy Kellogg for $3 billion

The Journal reported that WK Kellogg shareholders will receive $23 per share in cash—representing a premium of roughly 40% over recent trading levels. Including debt, the transaction gives WK Kellogg a total enterprise value of about $3.1 billion.

NCPA: PBM Reform Act must pass ASAP

NCPA: PBM Reform Act must pass ASAP

Systemic changes like those in the PBM Reform Act must pass and be enacted as soon as possible. We’re grateful for this bill’s introduction and will do everything we can to push it across the finish line.”